Sedia Biosciences Receives $1.0 Million NIH Grant for New HIV Diagnostic Assay

Avidity EIA, a novel single well enzyme assay based on U.S. Centers for Disease Control and Prevention licensed technology.

http://ift.tt/1dHEtQ1